The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy
β Scribed by Ge, Y; LaFiura, K M; Dombkowski, A A; Chen, Q; Payton, S G; Buck, S A; Salagrama, S; Diakiw, A E; Matherly, L H; Taub, J W
- Book ID
- 110058576
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 245 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
DNA isolated from blood or bone-marrow samples from 18 patients with acute non-lymphocytic leukemia (ANLL) and 14 patients with acute lymphocytic leukemia (ALL) was analyzed for the presence of mutations in the N-ras gene. Using synthetic oligonucleotide probes we detected mutations in 5 cases of AN
## Abstract ## BACKGROUND Much progress has been made in understanding the biology of acute lymphoblastic leukemia (ALL). This has translated into the recognition of several subgroups of ALL and the institution of riskβadapted therapies. New therapies are emerging based on the definition of specif
The nature of the bcl-2 family of protooncogenes was analyzed by sequence alignment, secondary structure prediction, and phylogenetic techniques. Phylogenies were inferred from both the nucleic acid and amino acid sequences of the human, murine, rat, and chicken sequences for BCL-2 and BCL-X, human